The University of Chicago Header Logo

Connection

John Edward A. Blair to Female

Back to Details
This is a "connection" page, showing publications John Edward A. Blair has written about Female.
John Edward A. Blair
Connection Strength
0.564
Female
  1. Use of Prospective Radiobrachial Angiography in Transradial Cardiac Catheterization and Intervention. Cardiovasc Revasc Med. 2020 06; 21(6):797-803.
    View in: PubMed
    Score: 0.035
  2. Coronary Microvascular Dysfunction and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction. J Card Fail. 2019 10; 25(10):843-845.
    View in: PubMed
    Score: 0.035
  3. Broken arrow: Successful retrieval of a dislodged coronary orbital atherectomy microtip. Catheter Cardiovasc Interv. 2018 09 01; 92(3):511-514.
    View in: PubMed
    Score: 0.032
  4. Electronic cardiac arrest triage score best predicts mortality after intervention in patients with massive and submassive pulmonary embolism. Catheter Cardiovasc Interv. 2018 08 01; 92(2):366-371.
    View in: PubMed
    Score: 0.032
  5. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2018 05 01; 314(5):H1033-H1042.
    View in: PubMed
    Score: 0.031
  6. Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report. ESC Heart Fail. 2017 11; 4(4):645-648.
    View in: PubMed
    Score: 0.030
  7. Diastolic Function and Transcatheter Aortic Valve Replacement. J Am Soc Echocardiogr. 2017 Jun; 30(6):541-551.
    View in: PubMed
    Score: 0.029
  8. Transcatheter Therapy for a Large Mobile Right Atrial Thrombus and Massive Pulmonary Embolism. J Invasive Cardiol. 2016 May; 28(5):E49-51.
    View in: PubMed
    Score: 0.027
  9. Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement. Am J Cardiol. 2016 Feb 15; 117(4):633-639.
    View in: PubMed
    Score: 0.027
  10. Regression of cardiac amyloid after autologous stem-cell transplantation. J Heart Lung Transplant. 2009 Jul; 28(7):746-8.
    View in: PubMed
    Score: 0.017
  11. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009 Jul; 30(13):1666-73.
    View in: PubMed
    Score: 0.017
  12. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol. 2008 Nov 11; 52(20):1640-8.
    View in: PubMed
    Score: 0.016
  13. Usefulness of hand-carried ultrasound to predict elevated left ventricular filling pressure. Am J Cardiol. 2009 Jan 15; 103(2):246-7.
    View in: PubMed
    Score: 0.016
  14. Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am J Ther. 2008 May-Jun; 15(3):231-40.
    View in: PubMed
    Score: 0.016
  15. Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome. Acute Card Care. 2007; 9(4):207-13.
    View in: PubMed
    Score: 0.014
  16. Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure. J Card Fail. 2021 10; 27(10):1045-1052.
    View in: PubMed
    Score: 0.010
  17. Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease. Vascular. 2021 Jun; 29(3):355-362.
    View in: PubMed
    Score: 0.009
  18. Impact of Loop Diuretic Use on Outcomes Following Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 09 15; 131:67-73.
    View in: PubMed
    Score: 0.009
  19. Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease. Catheter Cardiovasc Interv. 2019 Dec 01; 94(7):1028-1033.
    View in: PubMed
    Score: 0.009
  20. Quantitative detection of changes in regional wall motion using real time strain-encoded cardiovascular magnetic resonance. Magn Reson Imaging. 2020 02; 66:193-198.
    View in: PubMed
    Score: 0.009
  21. Monocyte and macrophage subtypes as paired cell biomarkers for coronary artery disease. Exp Physiol. 2019 09; 104(9):1343-1352.
    View in: PubMed
    Score: 0.009
  22. Percutaneous Transapical Left Ventricular Access to Treat Paravalvular Leak and Ventricular Septal Defect. J Invasive Cardiol. 2019 Sep; 31(9):247-252.
    View in: PubMed
    Score: 0.009
  23. Percutaneous Coronary Intervention following Placement of Sutureless Aortic Bioprostheses. Innovations (Phila). 2019 Apr; 14(2):177-182.
    View in: PubMed
    Score: 0.008
  24. Cost-utility of extracorporeal cardiopulmonary resuscitation in patients with cardiac arrest. Resuscitation. 2019 03; 136:126-130.
    View in: PubMed
    Score: 0.008
  25. Diagnosis of Isolated Cleft Mitral Valve Using Three-Dimensional Echocardiography. J Am Soc Echocardiogr. 2018 11; 31(11):1161-1167.
    View in: PubMed
    Score: 0.008
  26. Peak left atrial strain as a single measure for the non-invasive assessment of left ventricular filling pressures. Int J Cardiovasc Imaging. 2019 Jan; 35(1):23-32.
    View in: PubMed
    Score: 0.008
  27. Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation. Int J Cardiovasc Imaging. 2018 Oct; 34(10):1607-1617.
    View in: PubMed
    Score: 0.008
  28. Mechanical chest compressions improve rate of return of spontaneous circulation and allow for initiation of percutaneous circulatory support during cardiac arrest in the cardiac catheterization laboratory. Resuscitation. 2017 06; 115:56-60.
    View in: PubMed
    Score: 0.007
  29. 3D echocardiographic analysis of aortic annulus for transcatheter aortic valve replacement using novel aortic valve quantification software: Comparison with computed tomography. Echocardiography. 2017 May; 34(5):690-699.
    View in: PubMed
    Score: 0.007
  30. Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation. J Invasive Cardiol. 2016 Apr; 28(4):133-8.
    View in: PubMed
    Score: 0.007
  31. Intraoperative coronary artery dissection in fibromuscular dysplasia. Ann Thorac Surg. 2015 Apr; 99(4):1442-4.
    View in: PubMed
    Score: 0.006
  32. Abciximab-induced alveolar hemorrhage treated with rescue extracorporeal membranous oxygenation. Catheter Cardiovasc Interv. 2015 Apr; 85(5):828-31.
    View in: PubMed
    Score: 0.006
  33. Transradial cardiac catheterization in liver transplant candidates. Am J Cardiol. 2014 May 15; 113(10):1634-8.
    View in: PubMed
    Score: 0.006
  34. Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment. J Cardiovasc Med (Hagerstown). 2012 Jul; 13(7):415-22.
    View in: PubMed
    Score: 0.005
  35. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J. 2010 May; 159(5):841-849.e1.
    View in: PubMed
    Score: 0.005
  36. Use of hand carried ultrasound, B-type natriuretic peptide, and clinical assessment in identifying abnormal left ventricular filling pressures in patients referred for right heart catheterization. J Card Fail. 2010 Jan; 16(1):69-75.
    View in: PubMed
    Score: 0.004
  37. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J. 2009 Sep; 158(3):437-43.
    View in: PubMed
    Score: 0.004
  38. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009 Sep; 30(18):2233-40.
    View in: PubMed
    Score: 0.004
  39. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009 Jun; 157(6):1035-41.
    View in: PubMed
    Score: 0.004
  40. Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure. JACC Cardiovasc Imaging. 2008 Sep; 1(5):595-601.
    View in: PubMed
    Score: 0.004
  41. Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure. J Am Coll Cardiol. 2008 Jun 10; 51(23):2276-85.
    View in: PubMed
    Score: 0.004
  42. Reappraisal of the use of inferior vena cava for estimating right atrial pressure. J Am Soc Echocardiogr. 2007 Jul; 20(7):857-61.
    View in: PubMed
    Score: 0.004
  43. Radial artery pulse pressure variation correlates with brachial artery peak velocity variation in ventilated subjects when measured by internal medicine residents using hand-carried ultrasound devices. Chest. 2007 May; 131(5):1301-7.
    View in: PubMed
    Score: 0.004
  44. A comparison by medicine residents of physical examination versus hand-carried ultrasound for estimation of right atrial pressure. Am J Cardiol. 2007 Jun 01; 99(11):1614-6.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.